| Literature DB >> 35159286 |
Hadi Hashemzadeh1, Ali Hamad Abd Kelkawi1, Abdollah Allahverdi2, Mario Rothbauer3,4, Peter Ertl3, Hossein Naderi-Manesh1,2.
Abstract
Inadequacy of most animal models for drug efficacy assessments has led to the development of improved in vitro models capable of mimicking in vivo exposure scenarios. Among others, 3D multicellular spheroid technology is considered to be one of the promising alternatives in the pharmaceutical drug discovery process. In addition to its physiological relevance, this method fulfills high-throughput and low-cost requirements for preclinical cell-based assays. Despite the increasing applications of spheroid technology in pharmaceutical screening, its application, in nanotoxicity testing is still in its infancy due to the limited penetration and uptake rates into 3D-cell assemblies. To gain a better understanding of gold nanowires (AuNWs) interactions with 3D spheroids, a comparative study of 2D monolayer cultures and 3D multicellular spheroids was conducted using two lung cancer cell lines (A549 and PC9). Cell apoptosis (live/dead assay), metabolic activity, and spheroid integrity were evaluated following exposure to AuNWs at different dose-time manners. Results revealed a distinct different cellular response between 2D and 3D cell cultures during AuNWs treatment including metabolic rates, cell viability, dose-response curves and, uptake rates. Our data also highlighted further need for more physiologically relevant tissue models to investigate in depth nanomaterial-biology interactions. It is important to note that higher concentrations of AuNWs with lower exposure times and lower concentrations of AuNWs with higher exposure times of 3 days resulted in the loss of spheroid integrity by disrupting cell-cell contacts. These findings could help to increase the understanding of AuNWs-induced toxicity on tissue levels and also contribute to the establishment of new analytical approaches for toxicological and drug screening studies.Entities:
Keywords: cancer; cell culture techniques; metal nanoparticles; spheroid; toxicity test
Mesh:
Substances:
Year: 2022 PMID: 35159286 PMCID: PMC8834455 DOI: 10.3390/cells11030478
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 6.600
The chemical reagent and their details were used in this study.
| Activity | Chemical Reagent | Company |
|---|---|---|
| Spheroid generation microplate | Unknown | Corning® spheroid microplates 96 well |
| Live cells staining | Calcein-AM | Calbiochem (Merck Biosciences) |
| Dead cells staining | Ethidium Homodimer-1 (EthD-1) | Invitrogen, Thermo Scientific |
| Metabolic activity and cell proliferation | PrestoBlue Cell Viability Reagent | Invitrogen, Thermo Scientific |
Figure 1Live/dead assay of 3D multicellular spheroids and a 2D monolayer of A549 and PC9 lung cancer cells under treatments of different concentrations of AuNWs NPs evaluated by Calcein AM reagent: All AuNWs doses are per mL−1; Error bars represent ± SD (n = 3); ns is non-significance; *** p < 0.001; **** p < 0.0001 (highly significant); scale bar is 500 μm. The fluorescence images of A549 spheroids presented from right to left included dead cells stained with EthD-1, live cells stained with Calcein-AM, and merged.
Comparison of metabolic activity of 3D and 2D systems of A549 cancer cells treated with different concentrations of AuNWs at different times.
| 2D Monolayer | |||
|---|---|---|---|
| Conc. and Time | 2.5 mg/mL | 500 μg/mL | 50 μg/mL |
| 24 h | ** 58.89 ± 1.03 | ** 70.4 ± 3.33 | ns 98.3 ± 2.1 |
| 48 h | ** 11.5 ± 4.22 | * 74.3 ± 0.19 | ns 96.4 ± 1.09 |
| 72 h | ** 7.5 ± 2.65 | ** 27.5 ± 2.34 | ** 84.23 ± 3.09 |
|
| |||
| 24 h | ** 45.52 ± 3.76 | ** 88.74 ± 2.44 | ns 98.42 ± 2.87 |
| 48 h | ** 18 ± 2.5 | ** 68.98 ± 3.87 | ns 97.7 ± 2.47 |
| 72 h | ** 0 ± 0 | ** 24.4 ± 0.89 | ** 76.01 ± 2.49 |
Data are shown based on RFU: relative fluorescence intensity. Cell viability is directly related to metabolic activity and ultimately RFU. The quantitative results are the mean reduction of Resazurin reagent and the error bars represent ± SD (n = 3), ns is non-significance, * p < 0.05, ** p < 0.01.
Comparison of metabolic activity of 3D and 2D systems of PC9 cancer cells treated with different concentrations of AuNWs at different times.
| 2D Monolayer | |||
|---|---|---|---|
| Conc. and Time | 2.5 mg/mL | 500 μg/mL | 50 μg/mL |
| 24 h | ** 57.1 ± 1 | ** 82.1 ± 1.34 | ns 96.6 ± 1.7 |
| 48 h | ** 14.2 ± 2.09 | * 83.21 | ns 99.55 ± 2.4 |
| 72 h | ** 6.02 ± 1.14 | ** 22 ± 2.4 | ** 77.589± 1.9 |
|
| |||
| 24 h | ** 40.46 ± 2.93 | ** 81.3 ± 1.26 | ns 93.2 ± 1.14 |
| 48 h | ** 17.6 ± 4.09 | ** 66.6 ± 1.51 | ns 98.43 ± 2.07 |
| 72 h | ** 0 ± 0 | ** 20.22 ± 2.35 | ** 71.31 ± 1.3 |
Data are shown based on RFU: relative fluorescence intensity. Cell viability is directly related to metabolic activity and ultimately RFU. The quantitative results are the mean reduction of Resazurin reagent and the error bars represent ± SD (n = 3), ns is non-significance, * p < 0.05, ** p < 0.01.
Figure 2The surface area of 3D multicellular spheroids of A549 and PC9 lung cancer cells under treatment of different concentrations of AuNWs NPs: error bars represent ± SD (n = 3). The bright-field images of A549 spheroids from right to left include low integrity (cell–cell contacts) of spheroids treated to AuNWs, strong integrity (cell–cell contacts) of spheroids, and disrupted spheroids integrity (cell–cell contacts) of spheroids treated to AuNWs. The scale-bar is 500 μm.